Kai Lehmberg, MD
Dr. Kai Lehmberg did his undergraduate medical training in Kiel, Essen (Germany), and London (UK). He is a paediatrician at the Department of Paediatric Haematology and Oncology and the Division of Paediatric Stem Cell Transplantation and Immunology at the University Medical Centre Hamburg Eppendorf (Germany).
He has dedicated his scientific interest to clinical research in immune deficiencies and immune dysregulation with focus on haemophagocytic lymphohistiocytosis (HLH). His particular interest are stem cell transplantation for hereditary HLH and acquired forms of HLH with infectious, rheumatological, and malignant triggers.
Dr. Lehmberg heads the German national reference center for HLH in Hamburg (genetics, clinical counselling, cytology) and co-ordinates the data management of the international HLH registry, run by the Histiocyte Society and the European Society for Immune Deficiencies. He managed the European CureHLH project and coordinated the treatment studies HLH-2004 and EURO-HIT-HLH studies in Germany. He chairs the HS study group on HLH subtypes.